Anyone who has had IVF should know more or less about DHEA. Because most people need TOA supplementation when they do IVF. So what exactly is this DHEA? What does it do? Is everyone suitable for supplementing DHEA?
Do you know what happens most during pregnancy?
That had to be a frightening miscarriage, fetal abort, and congenital malformations. Before pregnancy, taking DHEA can largely help pregnant mothers improve the success rate of pregnancy, but also prevent miscarriage, fetal cessation and other situations.
So what exactly is DHEA and what does it do?
Pregnancy requires the combination of eggs and sperm before it can develop into an embryo. Then as a major egg production plant - the ovaries, it is particularly important.
Because of the pressure of contemporary women, bad living habits and other factors, many women have a decline in ovarian reserve function in advance. Then before preparing for pregnancy, improving ovarian function and allowing more women to achieve independent pregnancy is a top priority.
DHEA (dehydroepiandrosterone) is closely related to ovarian function, and the use of DHEA can increase the number of eggs acquired by IVF/ICSI in PATIENTS WITH DOR and improve egg quality, ultimately increasing the probability of pregnancy and childbirth.
DEHEA, also known as DHEA, is the most abundant body substance in the human blood circulation and is an important precursor hormone for steroid hormone synthesis in follicles.
What are the effects of DHEA supplementation when doing IVF?
DHEA helps improve the ovarian microenvironment of infertile women, thereby improving the quality of eggs and embryos. It can scientifically and effectively increase the pregnancy rate, thereby reducing the miscarriage rate. In patients with poor ovarian function, it is possible to improve the response of the ovaries and increase the number of follicles.
Is it that everyone who does test tubes need to supplement DHEA?
The answer is no. DHEA cannot be used in people with high polycystic ovaries or basal follicles. If use does not improve ovarian reserve, it may also cause endocrine disorders due to abnormal hormone levels.
Patients with advanced age and low ovarian response require supplementation 2 months before entering the IVF cycle, and can be discontinued after confirming pregnancy. A small number of patients require multiple consecutive nodul or IVF cycles to be taken continuously. Clinically, we recommend 75 mg daily for patients with poor ovarian function, preferably orally for 3 months before ovulation induction, hoping to improve outcomes in patients with low ovarian response.
Therefore, in general, DHEA has a good effect on improving ovarian function for advanced age and low ovarian response, while it is not so suitable for people with polycysts and more basal follicles.